Cardiac Disease After Breast Cancer Treatment: Make Sure to Check Our Blind Spot!

Affiliations

Editorial

Daniel J Lenihan. J Natl Cancer Inst. 2019.

. 2019 Aug 1;111(8):762-763.

doi: 10.1093/jnci/djy219.

Erratum in

Erratum.
[No authors listed] [No authors listed] J Natl Cancer Inst. 2019 Dec 1;111(12):1366. doi: 10.1093/jnci/djz031. J Natl Cancer Inst. 2019. PMID: 30920615 Free PMC article. No abstract available.

No abstract available

The Risk of Heart Failure and Other Cardiovascular Hospitalizations After Early Stage Breast Cancer: A Matched Cohort Study.
Abdel-Qadir H, Thavendiranathan P, Austin PC, Lee DS, Amir E, Tu JV, Fung K, Anderson GM. Abdel-Qadir H, et al. J Natl Cancer Inst. 2019 Aug 1;111(8):854-862. doi: 10.1093/jnci/djy218. J Natl Cancer Inst. 2019. PMID: 30715404 Free PMC article.

1. Abdel-Qadir H, Thavendiranathan P, Austin P, et al. The risk of heart failure and other cardiovascular hospitalizations after early stage breast cancer: a matched cohort study. J Natl Cancer Inst. 2019;1118:854–862. - PMC - PubMed
1. Chen J, Long JB, Hurria A, Owusu C, Steingart RM, Gross CP.. Incidence of heart failure or cardiomyopathy after adjuvant trastuzumab therapy for breast cancer. J Am Coll Cardiol. 2012;6024:2504–2512. - PubMed
1. Bowles EJ, Wellman R, Feigelson HS, et al. Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study. J Natl Cancer Inst. 2012;10417:1293–1305. - PMC - PubMed
1. Koene RJ, Prizment AE, Blaes A, Konety SH.. Shared risk factors in cardiovascular disease and cancer. Circulation. 2016;13311:1104–1114. - PMC - PubMed
1. Darby SC, Ewertz M, McGale P, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;36811:987–998. - PubMed